Söndag 19 April | 10:36:55 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-26 08:00 Kvartalsrapport 2026-Q3
2026-08-27 08:00 Kvartalsrapport 2026-Q2
2026-05-27 N/A X-dag ordinarie utdelning PRLD 0.00 SEK
2026-05-26 N/A Årsstämma
2026-05-26 08:00 Kvartalsrapport 2026-Q1
2026-02-26 - Bokslutskommuniké 2025
2025-12-10 - Split PRLD 100:1
2025-11-27 - Kvartalsrapport 2025-Q3
2025-11-19 - Extra Bolagsstämma 2025
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-30 - Årsstämma
2025-06-25 - X-dag ordinarie utdelning PRLD 0.00 SEK
2025-05-30 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-28 - Kvartalsrapport 2024-Q2
2024-05-27 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q1
2024-05-15 - X-dag ordinarie utdelning PRLD 0.00 SEK
2024-02-21 - Bokslutskommuniké 2023
2023-11-27 - Extra Bolagsstämma 2023
2023-11-27 - Kvartalsrapport 2023-Q3
2023-08-29 - Kvartalsrapport 2023-Q2
2023-05-12 - X-dag ordinarie utdelning PRLD 0.00 SEK
2023-05-11 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-21 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-08-29 - Kvartalsrapport 2022-Q2
2022-08-04 - Extra Bolagsstämma 2022
2022-05-23 - X-dag ordinarie utdelning PRLD 0.00 SEK
2022-05-20 - Årsstämma
2022-05-20 - Kvartalsrapport 2022-Q1
2022-02-22 - Bokslutskommuniké 2021
2021-11-23 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-06 - X-dag ordinarie utdelning PRLD 0.00 SEK
2021-05-05 - Årsstämma
2021-05-05 - Kvartalsrapport 2021-Q1
2021-02-24 - Bokslutskommuniké 2020
2020-11-17 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-05-21 - X-dag ordinarie utdelning PRLD 0.00 SEK
2020-05-20 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-20 - Kvartalsrapport 2019-Q3
2019-08-28 - Kvartalsrapport 2019-Q2
2019-05-16 - Årsstämma
2019-05-16 - Kvartalsrapport 2019-Q1
2019-05-10 - X-dag ordinarie utdelning PRLD 0.00 SEK
2018-11-20 - Kvartalsrapport 2018-Q3
2018-08-28 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning PRLD 0.00 SEK
2018-05-16 - Årsstämma
2018-05-16 - Kvartalsrapport 2018-Q1
2018-02-14 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-22 - X-dag ordinarie utdelning PRLD 0.00 SEK
2017-05-19 - Årsstämma
2017-05-19 - Kvartalsrapport 2017-Q1

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriMedicinteknik
Prolight Diagnostics utvecklar patientnära analyssystem, även benämnt som Point-Of-Care (POC) system. Dessa är små mobila instrument med engångstestkort som kan genomföra In-Vitro Diagnostiska (IVD) tester från en droppe blod. POC systemet kan bidraga till snabbare korrekta diagnoser av akuta tillstånd. Bolagets lanseringsprodukt blir högkänslig mätning av troponin för att kunna fastställa och utesluta hjärtinfarkt.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-04-14 16:32:00

Prolight Diagnostics, pioneer of point-of-care technology, today announces that they have been selected as a semi-finalist for the prestigious Disruptive Technology Award Competition (DTAC) organized by the Association for Diagnostics and Laboratory Medicine (ADLM). As a DTAC semi-finalist, Prolight are guaranteed exhibition space in the Disruptive Technology area at the ADLM annual meeting in Anaheim, California, July 26th-30th 2026.  

The six semi-finalists will present their technologies to the DTAC committee in early May to select three finalists who will present at a plenary session of the ADLM annual meeting in Anaheim, California on the 27thJuly. The winner will be selected at this session. 
 
“We are delighted to be selected as semi-finalist for this prestigious award, which demonstrates the rapid progress we are making with our single-molecule-counting point-of-care technology”, said Ulf Bladin, CEO of Prolight. ”Being selected as a semi-finalist is a clear testament to the disruptive nature of our technology, with this independent validation from a panel of industry experts serving as a strong endorsement of its capabilities.”
 
The ADLM 2026 Annual Scientific Meeting & Clinical Lab Expo is the premier global event for diagnostics and laboratory medicine with over 20,000 expected attendees and more than 800 exhibitors. The event features more than 250 educational sessions, covering a wide range of disciplines across diagnostics.
 
The Disruptive Technology Award was launched in 2018 to identify groundbreaking technologies that could transform the diagnostics industry. Their Mission Statement is: "ADLM's Disruptive Technology Award Competition (DTAC) aims to evaluate and elevate companies developing new diagnostic tools and technologies that have the potential to improve patient care. DTAC grants the diagnostic and laboratory medicine community an early look at innovative and impactful products that address current gaps in the field and/or improve upon existing solutions." 
 
The official announcement of the DTAC semifinalists is available here: https://meeting.myadlm.org/conference-program/disruptive-technology-award/contestants
 
Further information on ADLM can be found here: https://meeting.myadlm.org/about